FDA taking closer look at ER drugs; Capsugel buys ionic liquids IP; FDA's Yu says agency wants quality top of mind;

> The FDA's Lawrence Yu, acting director of CDER's Office of Pharmaceutical Science, says the agency is making progress on quality manufacturing. Report

> India's Immunologicals, part of the National Dairy Development Board, will build a new veterinary vaccine manufacturing facility in Pondicherry. Story

> Capsugel has acquired the intellectual property for the ionic liquids technology developed at the Monash Institute of Pharmaceutical Sciences, Monash University. Release

> Healthcare packaging maker Platinum Press has bought a 60,000-sq.-ft. packaging facility in Pine Brook, NJ. Report

> The FDA says it will begin taking a closer look at how well extended-release drugs work, including how they are manufactured. Story

Suggested Articles

Dr. Reddy’s says it has been told the FDA will not take regulatory action at its sterile formulations plant in Duvvada, Visakhapatnam.

The end is near for a GlaxoSmithKline OTC plant in Pennsylvania and its 260 employees. In fact, it has a date. 

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.